S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
S&P 500   4,288.05
DOW   33,507.50
QQQ   358.27
Powerball jackpot rises to $1.04 billion after another drawing without a big winner
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Who is Arthur Engoron? Judge weighing future of Donald Trump empire is Ivy League-educated ex-cabbie
Promoting tradition as well as beans, Ethiopian coffee shops find fans far from home
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
Federal student loan payments are starting again. Here's what you need to know
Native Hawaiian neighborhood survived Maui fire. Lahaina locals praise its cultural significance
Buy This Stock for AI Tidal Wave (not NVDA) (Ad)
A fight over precious groundwater in a rural California town is rooted in carrots
California governor rejects bill to give unemployment checks to striking workers
NASDAQ:TXMD

TherapeuticsMD (TXMD) Stock Forecast, Price & News

$3.02
+0.08 (+2.72%)
(As of 09/29/2023 ET)
Compare
Today's Range
$2.86
$3.02
50-Day Range
$2.89
$4.26
52-Week Range
$2.68
$7.53
Volume
12,456 shs
Average Volume
17,996 shs
Market Capitalization
$31.92 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

TherapeuticsMD MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
3.78% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.29mentions of TherapeuticsMD in the last 14 days
Based on 3 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.75) to $0.15 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

0.98 out of 5 stars

Medical Sector

958th out of 972 stocks

Pharmaceutical Preparations Industry

443rd out of 449 stocks


TXMD stock logo

About TherapeuticsMD (NASDAQ:TXMD) Stock

TherapeuticsMD, Inc. operates as a pharmaceutical company in the United States. It has a license agreement with Mayne Pharma to commercialize the IMVEXXY,BIJUVA, and ANNOVERA prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands. The company sells its prescription pharmaceutical products and prenatal vitamin products to wholesale distributors and retail pharmacy distributors. TherapeuticsMD, Inc. was founded in 2008 and is headquartered in Boca Raton, Florida.

TXMD Price History

TXMD Stock News Headlines

StockNews.com Begins Coverage on TherapeuticsMD (NASDAQ:TXMD)
TherapeuticsMD (NASDAQ:TXMD) Now Covered by StockNews.com
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
TheraputicsMD sells products rights for $153 million
See More Headlines
Receive TXMD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for TherapeuticsMD and its competitors with MarketBeat's FREE daily newsletter.

TXMD Company Calendar

Last Earnings
8/14/2023
Today
10/01/2023
Next Earnings (Estimated)
11/13/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:TXMD
Previous Symbol
NYSEMKT:TXMD
Employees
1
Year Founded
N/A

Profitability

Net Income
$112 million
Pretax Margin
41.70%

Debt

Sales & Book Value

Annual Sales
$69.96 million
Book Value
$3.73 per share

Miscellaneous

Free Float
10,448,000
Market Cap
$31.92 million
Optionable
Optionable
Beta
1.14
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Governor Thomas G. Thompson (Age 81)
    Exec. Chairman
    Comp: $150k
  • Mr. Marlan D. Walker J.D.Mr. Marlan D. Walker J.D. (Age 47)
    Chief Exec. Officer
    Comp: $1.13M
  • Mr. Robert G. FinizioMr. Robert G. Finizio (Age 52)
    Co-Founder
    Comp: $7.51k
  • Mr. Michael C. Donegan (Age 55)
    Interim CFO & Chief Accounting Officer
    Comp: $712.59k
  • Ms. Daniella Silva (Age 37)
    Chief Compliance Officer
  • Mr. Benjamin Foulk (Age 53)
    VP of HR
  • Mr. Bharat Warrier (Age 45)
    Chief Manufacturing Officer
  • Mr. Douglas Steelman
    VP of Market Access
  • Ms. Dedra Lyden
    VP of Strategic Partnerships & Initiatives













TXMD Stock - Frequently Asked Questions

Should I buy or sell TherapeuticsMD stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for TherapeuticsMD in the last year. There are currently 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should "hold" TXMD shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in TXMD, but not buy additional shares or sell existing shares.
View TXMD analyst ratings
or view top-rated stocks.

How have TXMD shares performed in 2023?

TherapeuticsMD's stock was trading at $5.59 on January 1st, 2023. Since then, TXMD stock has decreased by 46.0% and is now trading at $3.02.
View the best growth stocks for 2023 here
.

Are investors shorting TherapeuticsMD?

TherapeuticsMD saw a increase in short interest during the month of September. As of September 15th, there was short interest totaling 369,000 shares, an increase of 21.3% from the August 31st total of 304,300 shares. Based on an average daily trading volume, of 20,300 shares, the days-to-cover ratio is currently 18.2 days. Approximately 3.8% of the shares of the stock are sold short.
View TherapeuticsMD's Short Interest
.

When is TherapeuticsMD's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Monday, November 13th 2023.
View our TXMD earnings forecast
.

How were TherapeuticsMD's earnings last quarter?

TherapeuticsMD, Inc. (NASDAQ:TXMD) issued its earnings results on Monday, August, 14th. The company reported ($0.24) EPS for the quarter, missing analysts' consensus estimates of ($0.07) by $0.17. The company had revenue of $0.44 million for the quarter. TherapeuticsMD had a net margin of 61.23% and a trailing twelve-month return on equity of 232.35%.

When did TherapeuticsMD's stock split?

TherapeuticsMD shares reverse split on the morning of Monday, May 9th 2022. The 1-50 reverse split was announced on Monday, May 9th 2022. The number of shares owned by shareholders was adjusted after the closing bell on Monday, May 9th 2022. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

What other stocks do shareholders of TherapeuticsMD own?

Based on aggregate information from My MarketBeat watchlists, some companies that other TherapeuticsMD investors own include OPKO Health (OPK), Verastem (VSTM), Teva Pharmaceutical Industries (TEVA), Inovio Pharmaceuticals (INO), NVIDIA (NVDA), Sorrento Therapeutics (SRNE), Gilead Sciences (GILD), Cleveland-Cliffs (CLF), Novavax (NVAX) and Micron Technology (MU).

What is TherapeuticsMD's stock symbol?

TherapeuticsMD trades on the NASDAQ under the ticker symbol "TXMD."

How do I buy shares of TherapeuticsMD?

Shares of TXMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is TherapeuticsMD's stock price today?

One share of TXMD stock can currently be purchased for approximately $3.02.

How much money does TherapeuticsMD make?

TherapeuticsMD (NASDAQ:TXMD) has a market capitalization of $31.92 million and generates $69.96 million in revenue each year.

How can I contact TherapeuticsMD?

TherapeuticsMD's mailing address is 951 Yamato Road Suite 220, BOCA RATON FL, 33431. The official website for the company is www.therapeuticsmd.com. The company can be reached via phone at (561) 961-1900, via email at shareholder@broadridge.com, or via fax at 561-431-3389.

This page (NASDAQ:TXMD) was last updated on 10/1/2023 by MarketBeat.com Staff

My Account -